Back to list

HB Investment

HB Investment Inc. was founded on November 11, 1999 starting with paid-in Capital of KRW 10 billion. Since its foundation, HB Investment Inc. has been investing small and medium businesses that have the potential for steady growth and profitability and helping the invested companies to grow well by giving various consulting services. As a result, HB Investment Inc. constructed comprehensive portfolio out of various industrial areas, such as game, entertainment, as well as representative high-tech industries related to semiconductor, Internet, LCD, and a smart phone, bio, health care. In addition, HB Investment Inc. has experiences in implementing business Success-fully by organizing several partnership funds for recent years.
SH

Sung Hwan Bae

Director, Investment Review

SB

Seong-Hwan Bae

Director

YC

Young-Keun Choi

Director at Venture Investment Division

YJ

Yeong-Jin Jeon

Director

JJ

Jae-yeob Jeong

Director of Investment division

LJ

Lim Junki

Director, Chief Compliance Officer and CFO

HK

Hyung-jun Kim

Partner

SM

Seung Moon Lee

MD, Investment Associate

SL

Seung-Mun Lee

Director

GJ

Gwi Jin Lee

MD and General Manager of Merger and Acquisition

JL

Jun-Ki Lim

Director, Chief Compliances Officer and Head of Investment Management Division

SP

Sung-yong Park

VP

SP

Soo-yong Park

MD of the M&A Division

DP

Dong-Joo Park

Director, Investment Review

DP

Dong-ju Park

Director

HJ

Ha Jin Park

MD, Head of Investment Division 2

HJ

Hae Jin Park

MD, Head of Investment Team 1

JS

Jeong-sun Song

Director

MH

Min Hyun Yoon

MD and Investor General 1

MY

Min-Hyeon Yoon

MD and Head of Investment Division 2

26 past transactions

Mommaeat

Series B in 2021

CoDo

Pre Seed Round in 2020

M.MONSTAR

Series C in 2019

Posicube

Series B in 2021

BirdView Inc.

Series B in 2018
BirdView Inc. develops and provides Internet based mobile application for marketed cosmetics' review and information. It offers iOS and Android based platform, HwaHae, which allows users to review details regarding each component of a product. The company is headquartered in South Korea.

Odd Concepts

Series B in 2020
Odd Concepts Inc. develops computer vision and artificial intelligence technology solutions. The company’s products include an image recognition platform which is a portfolio of ready to use image recognition and search technology, as a cloud based API service and computer vision consulting. It develops an online software technology for video content searches to link offline shopping businesses to create O2O market. The company was incorporated in 2012 and is based in Seoul, South Korea.

AKUODIGITAL

Series B in 2021

BBB Inc.

Series B in 2018
BBB Technologies Inc. develops devices and applications that enable early stage diagnosis, better care, and treatment decisions. It creates blood testing technologies with mobile enabled tools and data insights for researchers, doctors, and patients worldwide. The company was founded in 2014 and is based in Mountain View, California with additional offices in Seoul, South Korea; and Shenzhen, China.

Lawfully

Seed Round in 2020

True Balance

Series C in 2019
True Balance is a digital wallet owned and operated by Balancehero India Private Limited (BHI), that enables users to access utility bill payment, loan recharge, insurance, and other financial products. With 70 million users, True Balance aims to serve India with utility payments financial platform for the unbanked users to serve their money for living requirements. It was launched in 2014 by Mr. Charlie Lee as CEO, an alumnus of the University of Chicago.
Curiox is a bioinstrumentation company spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore. Curiox has become a leader in the development and commercialization of innovative assay platforms based on its expertise in surface chemistry and engineering. Curiox’s vision is to accelerate the progress of life sciences, drug discovery and diagnostics through the miniaturization and improved automation of bioassays.

Vuno Inc.

Series A in 2016
Vuno offers artificial intelligence-based medical solutions for doctors and patients that provides a platform and consulting services for medical data analysis. Vuno develops automatic algorithm against various problems that occurs in medical sites as well as it develops diagnostic and quantification assisting software. The clients of the company are Asan Medical Center and HYUNDAI. The company offers VunoMed that provides different forms of data analyzation for medical videos, ECGs, brain waves, and EMR data. Vuno is located in South Korea and the company was founded in 2014 by Yeha Lee, Kyu-Hwan Jung, and Dannis Kim.
OKXE VIETNAM COMPANY LIMITED operates an online e-commerce platform for motorbikes. The platform enables users to buy and sell motorcycles online. The company was founded in 2018 and is based in Hanoi, Vietnam.

Studio XID, Inc.

Series A in 2020
Studio XID, Inc. develops ProtoPie, a prototyping tool for smart devices. Its ProtoPie allows users to compose elaborate interactions and animations, and build sensor-aided prototypes without any coding. The company’s ProtoPie solution comprises ProtoPie Studio, a software package that is installed on computers running Microsoft Windows or Mac OS X to allow users to explore design solutions, communicate designs, and research user feedback; and ProtoPie Player, an app that allows users to test prototypes created with ProtoPie Studio on smartphones. Its solution also supports the import of Sketch files. The company was founded in 2014 and is headquartered in Seoul, South Korea.

Studio XID, Inc.

Series A in 2022
Studio XID, Inc. develops ProtoPie, a prototyping tool for smart devices. Its ProtoPie allows users to compose elaborate interactions and animations, and build sensor-aided prototypes without any coding. The company’s ProtoPie solution comprises ProtoPie Studio, a software package that is installed on computers running Microsoft Windows or Mac OS X to allow users to explore design solutions, communicate designs, and research user feedback; and ProtoPie Player, an app that allows users to test prototypes created with ProtoPie Studio on smartphones. Its solution also supports the import of Sketch files. The company was founded in 2014 and is headquartered in Seoul, South Korea.

NeoNesia (Ezyload)

Series B in 2022

Siksin

Venture Round in 2017

Vuno Inc.

Series B in 2018
Vuno offers artificial intelligence-based medical solutions for doctors and patients that provides a platform and consulting services for medical data analysis. Vuno develops automatic algorithm against various problems that occurs in medical sites as well as it develops diagnostic and quantification assisting software. The clients of the company are Asan Medical Center and HYUNDAI. The company offers VunoMed that provides different forms of data analyzation for medical videos, ECGs, brain waves, and EMR data. Vuno is located in South Korea and the company was founded in 2014 by Yeha Lee, Kyu-Hwan Jung, and Dannis Kim.

Uberple

Series B in 2018
Uberple, Inc. owns and operates an online real-time statistical computing engine for financial research. Uberple, Inc. was founded in 2013 and is based in Seoul, South Korea.

MakinaRocks Co., Ltd.

Series A in 2020
Founded in December 2017, MakinaRocks is a startup specializing in industrial machine intelligence solutions. Our anomaly detection model and intelligent control algorithm analyze sensor and numeric data to provide intelligent control, improve product quality, and detect anomalies in manufacturing equipment. We deliver our industrial AI solutions to manufacturing industries such as semiconductor, automotive, battery, and energy.

HonestFund

Series B in 2018
HonestFund is a financial technology company operating an alternative investing platform in South Korea. HonestFund provides individuals and institutional investors access to alternative investment opportunities across a wide range of asset classes, such as residential/commercial real estates, infrastructure financing and unsecured personal loans. Due to its unique capability of providing a fully transparent and frictionless process for both investors and private issuers, HonestFund raised funds from leading financial institutions, including Shinhan Bank, Hanwha Investment, KB Investment, Shinhan Capital and Daily Financial Group.

Hummingbird Bioscience

Series B in 2019
Hummingbird Bioscience uses systems biology to develop insights into disease biology and applies computationally guided platforms to discover and engineer breakthrough biotherapeutics. The company is pursuing a broad pipeline of first drug candidates across multiple challenging targets with strong biological validation and disease association, including lead assets: HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, for the treatment of cancer. Hummingbird has established strategic collaborations with Cancer Research UK and Amgen, and has been awarded a product development grant from the Cancer Prevention and Research Institute of Texas.

CrowdWorks, Inc.

Series B in 2019
CrowdWorks, Inc. develops online crowd sourcing platform for artificial intelligent (AI) which engages in collecting, strengthening, and structuring leaning data for machine learning. The company offers its services for analysis and classifying of image works, text works, voice works, and survey works. The company is based in Seoul, South Korea.

Appro Mobile

Series A in 2021
Go2Joy (고투조이) is a mobile O2O platform connecting local hotels & local hotel users in Vietnam. Go2Joy is 1st Hourly/Overnight booking enabled OTA in Vietnam, and No.1 Hourly Hotel Booking app for young Vietnamese with largest user base, largest hourly booking hotel inventory, largest coverage in Vietnam

NeoNesia (Ezyload)

Series A in 2020

ILIAS Biologics

Series B in 2020
ILIAS Biologics is a biotechnology company that specializes in therapeutic molecules. The company features platform technology that enables experts to load large therapeutic molecules into exosomes. ILIAS Biologics is developing various therapeutic exosomes, a potential treatment for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.